Werner J. Struss
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy.
Journal: BJU international
Published: June 01, 2023
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score-weighted comparative cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 18, 2021
The impact of perioperative complications on favorable outcomes after artificial urinary sphincter implantation for post-prostatectomy incontinence.
Journal: International braz j urol : official journal of the Brazilian Society of Urology
Published: September 26, 2019
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Journal: European urology
Published: September 21, 2018
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.
Journal: Journal of cellular physiology
Published: August 30, 2018
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.
Journal: The Journal of pathology
Published: March 15, 2018
Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: February 13, 2018
A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer.
Journal: World journal of urology
Published: August 14, 2017
Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-sensitive Prostate Cancer.
Journal: Urology
Published: July 25, 2017
The impact of time to metastasis on overall survival in patients with prostate cancer.
Journal: World journal of urology
Published: July 14, 2017
Magnetically-actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot study.
Journal: The Prostate
Published: June 29, 2017
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib.
Journal: Oncotarget
Published: June 20, 2017
Last Updated: 09/26/2026